Britannia Life Sciences Inc's total assets for Q3 2024 were C$22.17M, a decrease of -2.59% from the previous quarter. TSE:BLAB total liabilities were C$16.33M for the fiscal quarter, a -1.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.